Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RiteMED is the leading provider of affordable, high-quality generic medicines in the Philippines. Established in 2002 as a subsidiary of United Laboratories (Unilab), the company was created to provide Filipinos with access to essential healthcare through a wide portfolio of off-patent drugs. Its product line covers various therapeutic areas, including cardiovascular health, metabolic diseases, anti-infectives, and respiratory conditions. RiteMED is well-known for its extensive marketing campaigns and strong distribution network across the Philippine archipelago. The company operates primarily as a marketing and distribution entity for generic pharmaceuticals manufactured under strict quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RiteMED.